Aurex Laboratories

Windsor, Canada Founded: 2014 • Age: 12 yrs Acquired By Apnar Pharma
Drug manufacturing for multiple therapeutic areas is conducted through RD.
Annual revenue $166,946 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Aurex Laboratories

Aurex Laboratories is a company based in Windsor (Canada) founded in 2014 was acquired by Apnar Pharma in February 2022. Aurex Laboratories offers products and services including DEPO288 Platform and Promotions Service.

  • Headquarter Windsor, Canada
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aurex Laboratories Private Limited
  • Date of Incorporation 11 Aug, 2015
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $166.95 K (USD)
    181.91
    as on Mar 31, 2023
  • Net Profit
    -$80.05 K (USD)
    10.7
    as on Mar 31, 2023
  • EBITDA
    -$75.88 K (USD)
    -12.21
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Apnar Pharma

    (Feb 07, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aurex Laboratories

Aurex Laboratories offers a comprehensive portfolio of products and services, including DEPO288 Platform and Promotions Service.

Primary

Platform for accessing online games with secure login.

Offers vouchers and discounts for gaming activities.

Funding Insights of Aurex Laboratories

Investors in Aurex Laboratories

Aurex Laboratories has secured backing from 1 investor. Prominent investors backing the company include Apnar Pharma.

All
Investor Description Founded Year Domain Location
Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables.
Founded Year Domain Location

Investments & Acquisitions by Aurex Laboratories

Investments

Financial Statements - Aurex Laboratories

Aurex Laboratories Comparisons

+
Add Comparison
Available on Premium

Competitors of Aurex Laboratories

Latest news on Aurex Laboratories

APNAR Pharma Acquires Aurex Laboratories
Contractpharma4 years ago

Frequently Asked Questions about Aurex Laboratories

Aurex Laboratories was founded in 2014.

Aurex Laboratories is headquartered in Windsor, Canada. It is registered at Windsor, Ontario, Canada.

Ranga Aravapalli is the current CEO of Aurex Laboratories.

Annual revenue of Aurex Laboratories is $166.95K as on Mar 31, 2023.

Aurex Laboratories was established in 2014 in Windsor, Canada, within the pharmaceutical sector. Research and development efforts are directed toward the manufacturing of drugs across various therapeutic areas. Operations encompass the production of pharmaceutical products to support diverse medical needs. Leadership is provided by Ranga Aravapalli, serving as CEO. The companys domain, aurexlabs.com, facilitates its activities in this field.

Aurex Laboratories offers DEPO288 Platform and Promotions Service.

Aurex Laboratories has 1 investor. Key investors include Apnar Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available